This announcement is a separate document:
奥赛康：关于子公司马来酸奈拉替尼片获得药品注册证书的公告
Osecon: Announcement on Subsidiary Nelatinib Maleate Tablets Obtaining a Drug Registration Certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated